J Rheumatol
-
Randomized Controlled Trial Multicenter Study
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
This study compared the immunogenicity of influenza and pneumococcal vaccines in adult patients with rheumatoid arthritis (RA) receiving adalimumab or placebo. ⋯ Patients with RA treated with adalimumab can be effectively and safely immunized with pneumococcal and influenza vaccines.